Cargando…
URB2 as an important marker for glioma prognosis and immunotherapy
Introduction: Glioma is the most common primary brain tumor and primary malignant tumor of the brain in clinical practice. Conventional treatment has not significantly altered the prognosis of patients with glioma. As research into immunotherapy continues, glioma immunotherapy has shown great potent...
Autores principales: | Fang, Chaoyou, Zhang, Zeyu, Han, Yongquan, Xu, Houshi, Zhu, Zhengyang, Du, Yichao, Hou, Pinpin, Yuan, Ling, Shao, Anwen, Zhang, Anke, Lou, Meiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080038/ https://www.ncbi.nlm.nih.gov/pubmed/37033651 http://dx.doi.org/10.3389/fphar.2023.1113182 |
Ejemplares similares
-
Natural Products for the Treatment of Post-stroke Depression
por: Fang, Chaoyou, et al.
Publicado: (2022) -
Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future
por: Zhu, Zhengyang, et al.
Publicado: (2022) -
SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma
por: Xu, Houshi, et al.
Publicado: (2022) -
TRP Family Genes Are Differently Expressed and Correlated with Immune Response in Glioma
por: Fang, Chaoyou, et al.
Publicado: (2022) -
Natural Compounds for SIRT1-Mediated Oxidative Stress and Neuroinflammation in Stroke: A Potential Therapeutic Target in the Future
por: Fang, Chaoyou, et al.
Publicado: (2022)